Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T8XB
|
||||
Former ID |
DNCL002831
|
||||
Drug Name |
Anagliptin
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Kowa Research Institute
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H25N7O2
|
||||
Canonical SMILES |
CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N
|
||||
InChI |
1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1
|
||||
InChIKey |
LDXYBEHACFJIEL-HNNXBMFYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Modulator | [544067] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.